Biotechnology

WuXi PharmaTech Inc. , a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations inChina andthe United States, today announced that Dr. Ge Li, the Company's Chairman and Chief Executive Offic

Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the placement of a next-generation protein analysis system prototype, the Cell Biosciences CB1000, at the Stanford University School of Medi

The Medicines Company is scheduled to participate in the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13th, at 9am Pacific Time, 12:00pm Eastern Time. A company overview and outlook will be provided in the presentation.

Novacea, Inc. announced today an upcoming special meeting of Novacea stockholders to vote on matters related to the proposed merger between Novacea and Transcept Pharmaceuticals, Inc. The meeting is scheduled to be held at 9:00 a.m. Pacific on Tuesday, J

ALDA Pharmaceuticals Corp. announces that a new DIN has been issued by Health Canada for T36 Antiseptic Hand Sanitizer in liquid form. This new product complements ALDA's previously approved T36 Antiseptic Hand Sanitizer Gel and allows the formulation to

InterMune, Inc. today announced that Daniel G. Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 27th Annual J.P. Morgan Healthcare Conference inSan Francisco on January 15, 2009 at 1:00 p.m. PST.

Medarex, Inc. announced today that it is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference at 8:30 a.m. Pacific Time on Tuesday, January 13, 2009. The event will be webcast live and will be available in the Investor Relations sect

Pharmacyclics, Inc. today announced that in preparation of further equity offerings, Robert W. Duggan & Associates made an unsecured loan to Pharmacyclics, Inc. on December 30, 2008, in the amount of $5,000,000. As of December 31, 2008, the company's